Relation of plasma xanthine oxidation-reduction enzyme activity and various factors in patients with cardiovascular disease and/or heart failure

Relation of plasma xanthine oxidation-reduction enzyme activity and various factors in patients with cardiovascular disease and/or heart failure - Xanthine oxidation-reduction enzyme activity in patients with cardiovascular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022274

Enrollment

100

Registered

2016-05-11

Start date

2016-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male or female patients over 20 years old at time the subjects sign the Informed Consent Form (ICF).

Exclusion criteria

Exclusion criteria: Patients who are judged as inappropriate for inclusion by physicians.

Design outcomes

Primary

Measure	Time frame
Measured value of the plasma XOR activity in patients with cardiovascular disease	—

Secondary

Measure	Time frame
Measured value of the plasma XOR activity in patients with heart failure	—

Countries

Japan

Contacts

Public ContactYumiko Kanzaki

Osaka Medical College Department of Cardiology

in3089@poh.osaka-med.ac.jp072-683-1221

Outcome results